Clinical trial

Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients…

NCT00469820 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Terminated

Key facts

NCT number NCT00469820
Title Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant
Official title Posttransplant Immunotherapy With Donor Lymphocyte Infusions and Autologous Tumor Vaccines After HLA-Matched Transplant
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Phase 1
Study type Interventional
Conditions Leukemia, Multiple Myeloma and Plasma Cell Neoplasm
Intervention type Biological
Interventions autologous tumor cell vaccine, peripheral blood lymphocyte therapy
Enrollment 1
Start date Apr 1, 2007
Primary completion Mar 1, 2010
Completion Mar 1, 2010
First posted May 7, 2007
Last update posted Mar 21, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies